1st Quarter - Report
FORBES-TATE for VIR BIOTECHNOLOGY, INC.
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Healthcare initiatives related to novel antibody technology platform; Issues related to COVID funding; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| PAUL DIOGUARDI | — |
| KRISTINA DUNKLIN | — |
| ELIZABETH GREER | — |
| RICHARD FERNANDO LOPEZ | — |
| FRANCESCA MCCRARY | — |
| EDWARD C. RENO | — |
| JEFFREY SADOSKY | — |
| BARRETT THORNHILL | — |
| WESLEY RYAN WELCH | — |
| DERRICK M WHITE | — |
| ZACHARY WILLIAMS | — |
Government Issues GOV
Healthcare initiatives related to novel antibody technology platform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| PAUL DIOGUARDI | — |
| KRISTINA DUNKLIN | — |
| ELIZABETH GREER | — |
| RICHARD FERNANDO LOPEZ | — |
| FRANCESCA MCCRARY | — |
| EDWARD C. RENO | — |
| JEFFREY SADOSKY | — |
| BARRETT THORNHILL | — |
| WESLEY RYAN WELCH | — |
| DERRICK M WHITE | — |
| ZACHARY WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.